Ablation Index : A new standard for Safety and Efficacy. Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France

Similar documents
Mapping and Ablation in AF: how can we evaluate the lesion formation?

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

AF ablation Penn experience. Optimal approach to the ablation of PAF: Importance of identifying triggers 9/25/2009

Catheter Ablation of Atrial Fibrillation

Fibrillation Atriale Paroxystique : ablation, résultats, complications

New technology to minimize radiation

Mapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

20% 10/9/2018. Fluoroless Ablation relinquishing an old habit. Prevalence of Atrial Fibrillation. Atrial Fibrillation is a Progressive Disease

Balloon and Mesh Catheter Ablation of Pulmonary Veins

AF ABLATION Concepts and Techniques

Integration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation

Pulmonary Vein Isolation for AF RF or Cryo? Dr. Yuen Ho Chuen Princess Margaret Hospital

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

ABLATION TECHNIQUES FOR ATRIAL FIBRILLATION

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Storia dell ablazione della fibrillazione atriale: da dove siamo partiti, dove siamo, dove andremo. Prof. Fiorenzo Gaita

How to improve procedural outcome of cryoballoon ablation in persistent AF Experience from Redo procedures

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Complications During Cardiovascular Interventions: Management and Prevention

Atrial Fibrillation Ablation: in Whom and How

Debate-STAR AF 2 study. PVI is not enough

CLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

Complex Left Atrial (CLA) Best Practices for Navigant

Ablation Lesion Assessment

Long Standing Persistent AF ; CPVI is enough for it

High density substrate mapping In AF

Ablation of persistent AF Is it different than paroxysmal?

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

1995 Our First AF Ablation. Atrial Tachycardias During and After Atrial Fibrillation Ablation. Left Atrial Flutter. 13 Hours Later 9/25/2009

What s new in my specialty?

Stand alone maze: when and how?

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

INTRODUCTION. Key Words:

Atrial fibrillation (AF), the most sustained cardiac arrhythmia

Catheter ablation of AF Where do we stand, where do we go?

UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?


Erik Wissner, MD, F.A.C.C. Asklepios Klinik St. Georg Hamburg, Germany on behalf of the VTACH Study group

SEVEN YEARS OF CRYO-BALLOON CATHETER ABLATION

Introduction. CLINICAL RESEARCH Ablation for atrial fibrillation

Outcomes of AF Ablation

Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Electrical isolation of the pulmonary veins (PVs) to treat

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

Introduction. CLINICAL RESEARCH Ablation for atrial fibrillation

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY

CLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) Trial

Cardiology Department, Ain Shams University, Cairo, Egypt.

Ablation of atrial fibrillation Techniques and workflow in AF rotors. G. Hindricks and Ph. Sommer

Surgical Ablation for Lone AF: What have we learned after 30 years?

Samuel Asirvatham, MD & Enrique Melgarejo Rojas, MD Saturday, June 24, :40 to 3:25 p.m.

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

Persistent AF: when and why using the Cryo Technology

Biatrial Maze or PVI to Ablate Afib? Marc Gillinov, MD

Bipolar Radiofrequency Energy

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Jesus M. Paylos, C. Ferrero, L. Azcona, A. Morales, M. A. Vargas, L. Lacal, V. Gomez Tello.

The Future of Catheter Ablation

974 ZUCCHELLI G et al. Circ J 2018; 82: ORIGINAL ARTICLE doi: /circj.CJ

Original Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*

Atrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016

Atrial Fibrillation 2009

Initial Experience Using AutoMark in Atrial Fibrillation Ablation

Catheter ablation is a well-established treatment for

The lesion characteristics assessed by LGE-MRI after the cryoballoon ablation and conventional radiofrequency ablation

Mapping and Ablation of Challenging Outflow Tract VTs: Pulmonary Artery, LVOT, Epicardial

Supplementary Online Content

A MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

One-year clinical success of a no-bonus freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation

Atrial Fibrillation and Sleep Apnea. Farhat S. Khairallah, MD, FHRS, FACC

8/26/2016. Historical Perspective (1) Is Cryoballoon the Preferred Approach to Ablation of Paroxysmal AF? Historical Perspective (2)

Radiofrequency Energy: Irrigation and Alternate Catheters. Andreas Pflaumer

Modifiable Up-Stream Risk Factors:

Rotor Mapping A FIRM Foundation Exists

Treatment of Atrial Fibrillation in Heart Failure

Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary

Ablation Update and Case Studies. Lawrence Nair, MD, FACC Director of Electrophysiology Presbyterian Heart Group

ViewFlex Xtra ICE Catheter. Positioning Reference Manual

Trial design and selection criteria

Hybrid Surgical Ablation in South America: Lesson Learned. Joao R. Breda

Precise lesion formation is crucial for successful

Division of Cardiology, Northwestern University, Feinberg School of Medicine.

Can the UK afford ablation for persistent AF? cost efficacy analysis. Dr Derick Todd Liverpool Heart & Chest Hospital

Pulmonary vein isolation (PVI) has become the cornerstone. Original Article

Transcription:

Ablation Index : A new standard for Safety and Efficacy Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France

Disclosures Dr Franck Halimi... I have the following potential conflicts of interest to report: Consulting: - Medtronic, Saint Jude Medical, Boston Scientific, Biotronik, Johnson & Johnson Employment in industry: 0 Shareholder in a healthcare company: 0 Owner of a healthcare company: 0 Other(s): 0

Background: Contact force technology First name - last name Has become a new standard for catheter ablation AF ablation Evidences for Better acute PVI and long term outcomes Improved safety

2013

Primary and secondary acute endpoints in CF vs. Control group Effective acute PVI using an anatomical approach (no lasso)

Proportion of pts free of AF during the 12- month FU (3 months blanking period) Kaplan-Meier curve Primary mid-term endpoint

Time to first AF / atrial flutter / atrial tach recurrence through 12 months FU Kaplan-Meier curve Investigators working in their selected ranges

What are the missing information to create consistent and safe lesions? First name - last name Catheter stability Lesion continuity Visitag* Amount of energy for each RF pulse? Contact force magnitude Power settings RF duration Ablation Index*

First name - last name Catheter stability assessed by CARTO 3 Visitag* Module Visitag* are automatic tags that give valuable information on Catheter stability in mm (respiration gating) Minimum application time in sec Predefined range of contact force in grams

Importance of stability on ablation size 10 g 30 sec 25 W ablation 4m m 2 mm No movement 3mm movement (after 15sec)

Lesion continuity with Visitag* Contiguous tags to avoid gaps Dr F. Halimi, Parly 2

Linear lesions using 3D tags (floating points) Dr F. Halimi, Parly 2

Visitag* Study (ongoing) Single operator, Single center (Parly 2) Consecutive PAF, 1st procedure CARTO 3 and SmartTouch* catheters Inclusion 07/2012 to 07/2015 2 groups : CF / Visitag* OFF : 22 pts CF / Visitag* ON : 33 pts Follow-up : Clinical FU 24h-Holter at 3, 6 and 12 months Dr F. Halimi, Parly 2

Visitag* Study Results +24,3% p=0,18 90,0 80,0 70,0 69,1-45,1% 68,2 84,8 60,0 50,0 40,0 30,0 38,0-12,1% 34,8 30,6 20,0-46,8% 10,0 0,0 3,7 2,0 fluoroscopy time (min) radiation exposure (mgy/cm²) RF time (min) Primary endpoint, % Visitag OFF VISITAG ON Dr F. Halimi, Parly 2

The CARTO 3 Ablation Index* Provides automatic composite tag combining Contact force Power Application time (catheter in a stable position)

Ablation Depth VS. Time with constant contact force Using an irrigated catheter, Lesion Depth as function of RF Duration for different power levels represents non-linear progression. Contact Force is constant. http://www.mate.tue.nl/mate/pdfs/10447.pdf Experimental and Numerical Analysis of Lesion Growth during Cardiac Radiofrequency Ablation Sytske Foppen BMTE 09.14, April 2009

Lesion Depth by Time for Variable Power & Contact-Force The Animal Model and Simulated Model show similar behavior. The effect of increased power is more significant than contact force. The ablation Depth graphs reflect a nonlinear relation with time for diverse Contact-Force and Power.

HRS 2012, Hiroshi Nakagawa, MD, PhD et al Ablation Index Formula versus Actual Lesion Depth CF: Contact Force, P: RF Power, t: Application Time Accuracy ±1mm (90%) Actual Lesion Depth (mm) n=161 No Pop FPTI Formula Predicted Lesion Depth (mm) (FPTI: Force Power Time Index)

Clinical Prospective Study High Incidence of Ipsilateral Pulmonary Vein Isolation by First Encirclement Using New Force-Power-Time Formula with Short Radiofrequency Time in Atrial Fibrillation Patients Methods: 43 PAF patients (2 centers) had PVI. Two Ablation Index target numbers were used: Anterior/superior segments (Represented by tag size 3 - Dark red) Posterior/inferior segments (Represented by tag size 2 - Orange) RF was delivered until Force Power Time Index reached target number or esophageal temperature reached 40C. RF power was increased at low CF and decreased at high CF.. LSPV LIPV LA in PA Projection RSPV RIPV Tag Size 2 Tag Size 3 Nakagawa, et al. Heart Rhythm PO03-102. Vol. 12, (5), May Supplement 2015

Results & Conclusions Results Median Range Contact force 15g 3-64g Parameters per application Power 35w 17-50w Complete Ip - PVs isolation 77/86 (90%) Time 28 sec 6-93 sec Adenosine reconnection 4/86 (5%) Ip-PVsi Circum. Length 12.2 cm 8-16.5 cm Follow Up (2-11 months) no tachycardia 42/43 (98%) Conclusions: Ablation Index guidance produced complete ipsilateral PV isolation by a single encirclement in 90% using short RF time

Ablation Index* targeted values First name - last name At this point there are no predefined Ablation Index* values Each operator has to perform 10 blinded cases with retrospective Ablation Index* calculation per segment

My early experience 10 blinded cases First name - last name 13 PAF (ongoing) Third group to the Visitag* Study CF / Visitag* OFF CF / Visitag* ON CF / Ablation Index* 3D tags only (stability / lesion continuity) Dr F. Halimi, Parly 2

My Ablation Index values per segment Ridge 420 Anterior 400 Dr F. Halimi, Parly 2

Infero-sup / Carena 350 Posterior 320 Dr F. Halimi, Parly 2

First results: RF time Variable Visitag N Missing Mean S.D. RF time (s) No 25 0 1995 938 Yes 49 0 1813 455 Ablation Index 13 0 1587 350 26 min Total 87 0 1832 628 Dr F. Halimi, Parly 2

First results: X ray exposure Fluoro (seconds) Variable Visitag N Missing Mean S.D. Fluoroscopy time (s) No 25 0 230 93 Yes 49 0 102 49 Ablation 13 0 49 16 Index Total 87 0 131 90 Air Kerma (mgy/cm2) Variable Visitag N Missing Mean S.D. Air Kerma, dose (mgy/cm²) No 23 2 69 36 Yes 45 4 40 19 Ablation 13 0 25 15 Index Total 81 6 46 29 Dr F. Halimi, Parly 2

First Results with Ablation Index* 100 100 90 80 70 69 60 50 40 30 20 10 0 40 33 30 26 25 3,8 1,7 0,8 RF time (min) Fluoro time (min) DAP (mgy/cm2) Acute success PVI (%) Visitag OFF Visitag ON Ablation Index Dr F. Halimi, Parly 2

Conclusion 1 Ablation Index* leads to a tailored RF strategy taking into consideration a combination of contact force and power to determine RF time for each stable application Slight changes in procedure workflow First name - last name Early results show Reduction in RF delivery Reduction in X Ray exposure 100% of acute PVI

Conclusion 2 First name - last name There are strong evidences supporting that Ablation Index* provides high per-procedural efficacy and increased safety Results of the CLOSE Study will soon be published in Circulation with excellent long term outcomes after a single procedure